Tytuł artykułu
Autorzy
Identyfikatory
Warianty tytułu
Konferencja
1st Symp. on NMR in Chemistry, Biology and Medicine; 8-10 Semptember, Warsaw, Poland. Issue dedicated to honour Prof. Witanowski
Języki publikacji
Abstrakty
Procedures for enantiomeric recognition of 2-hydroxyglutaric acid and 5-oxoproline - markers ofmetabolic diseases, and of vigabatrin - an antiepileptic drug, suitable for urine samples, have been elaborated. They rely upon derivatization of the metabolites with a chiral reagent; this is made without separation of these compounds from a biological sample. The diastereotopic metabolite derivatives are then distinguished using 13C or 19F NMR spectroscopy. This procedure is not so simple as one proposed previously, but, as opposite to the latter method, it seems to be unfailing and still not too complicated.
Słowa kluczowe
Wydawca
Czasopismo
Rocznik
Tom
Strony
1021--1030
Opis fizyczny
Bibliogr. 27 poz., rys.
Twórcy
autor
autor
- Faculty of Chemistry, Warsaw University of Technology, Noakowskiego 3, 00-664 Warsaw, Poland
Bibliografia
- 1. Sewell A.C., Heil M., Podebrad F. and Mosandl A., Eur. J. Pediatr., 157, 185 (1998).
- 2. Heil M., Podebrad F., Beck T., Mosandl A., Sewell A.C. and Bohles H., J. Chromatogr. B, 714, 119 (1998).
- 3. Rashed M.S., Aboul-Enein H.Y., AlAmoudi M., Jakob M., Al-Ahaideb L.Y., Abbad A., Shabib S. and Al-Jishi E., Biomed. Chromatogr., 16, 191 (2002).
- 4. Duran M., Ketting D., Kamerling J.P., Gerwig G.J., Yliegenthart J.F.G. and Wadman S.K., J. Chromatogr., 143, 117(1977).
- 5. Chalmers R.A., Lawson A.M., Watts R.W.E., Tavill A.S., Kamerling J.P., Hey E. and Ogilvie D., J. Inher. Metab. Dis., 3, 11 (1980).
- 6. Duran M., Kamerling J.P., Bakker H.D., van Gennip A.H. and Wadman S.K., J. Inher. Metab. Dis., 3, 109(1980).
- 7. Barth P.G., Hoffmann G.F., Jaeken J., Wanders R.J.A., Duran M., Jansen G.A., Jakobs C., Lehnert W., Hanefeld F., Valk J., Schutgens R.B.H., Trefz F.K., Hartung H.P., Chamoles N.A., Sfaello Z. and Caruso U., J. Inher. Metab. Dis., 16, 753 (1993).
- 8. Rashed M.S., AlAmoudi M. and Aboul-Enein H.Y., Biomed. Chromatogr., 14, 317 (2000).
- 9. Pitt J.J. and Hauser S., Clin. Chem., 44, 1497 (1998).
- 10. Gatti G., Bonomi L, Jannuzzi G. and Perucca E., Curr. Pharm. Design, 6, 839 (2000).
- 11. Tomson T.J., J. Neurol, 251, 1043 (2004).
- 12. Vauzelle-Kervroedan F., Rey E., Pons G., d'Athis P, Chiron C., Dulac O., Dumas C. and Olive G., Br. J. Clin. Pharmacol, 42, 779 (1996).
- 13. Vermeij T.A.C. and Edelbroek P.M., J. Chromatogr. B, 716, 233 (1998).
- 14. Vallat C., Rivier F., Bellet H., de Bomier B.M. and Mion H., Epilepsia, 37, 803 (1996).
- 15. Lahat E., Ben-Zeev B., Złotnik J. and Sela B.A., Pediatr. Neurol., 21, 460 (1999).
- 16. Podebrad F., Heil M., Beck T., Mosandl A., Sewell A.C. and Bohles H., Clin. Chim. Acta, 292,93 (2000).
- 17. Bal D., Gradowska W. and Gryff-Keller A., J. Pharm. Biomed. Anal, 28, 1061 (2002).
- 18. Winitz M., Bloch-Frankenthal L., Izumiya N., Birnbaum S.M., Baker C.G. and Greenstein J.P., J. Am. Chem. Soc., 78, 2423 (l956).
- 19. Saijo S., Wada M., Himizu J. and Ishida A., Chem. Pharm. Bull., 28, 1449 (1980).
- 20. Wei Z.Y. and Knaus E.E., Tetrahedron, 50, 5569 (1994).
- 21. Dale J.A., Duli D.L. and Mosher H.S., J. Org. Chem., 34, 2543 (1969).
- 22. Rothchild R., Enantiomer, 5, 457 (2000).
- 23. Wenzel T.J. and Wilcox J.D, Chirality, 15, 256 (2003).
- 24. Peters J.A., Huskens J. and Raber D.J., Prog. Nucl. Magn. Reson. Spectrosc., 28, 283 (1996) .
- 25. Seco J.M., Quinoa E. and Riguera R., Chem. Rev., 104, 17 (2004).
- 26. Sullivan G.R., Dale J.A. and Mosher H.S., J. Org. Chem., 38, 2143 (1973).
- 27. Tran A., O'Mahoney T., Rey E., Mai J., Mumford J.P. and Olive G., Br. J. Clin. Pharmacol, 45, 409 (1998).
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-article-BUJ6-0007-0003